Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verrica Pharmaceuticals (VRCA) Non-Current Assets (2021 - 2025)

Historic Non-Current Assets for Verrica Pharmaceuticals (VRCA) over the last 5 years, with Q3 2025 value amounting to $4.6 million.

  • Verrica Pharmaceuticals' Non-Current Assets fell 251.05% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.6 million, marking a year-over-year decrease of 3160.07%. This contributed to the annual value of $3.0 million for FY2024, which is 2734.2% down from last year.
  • According to the latest figures from Q3 2025, Verrica Pharmaceuticals' Non-Current Assets is $4.6 million, which was down 251.05% from $2.3 million recorded in Q2 2025.
  • Over the past 5 years, Verrica Pharmaceuticals' Non-Current Assets peaked at $6.1 million during Q2 2022, and registered a low of $2.3 million during Q2 2025.
  • For the 5-year period, Verrica Pharmaceuticals' Non-Current Assets averaged around $4.9 million, with its median value being $5.4 million (2023).
  • In the last 5 years, Verrica Pharmaceuticals' Non-Current Assets skyrocketed by 776.17% in 2022 and then crashed by 5042.63% in 2025.
  • Verrica Pharmaceuticals' Non-Current Assets (Quarter) stood at $5.8 million in 2021, then decreased by 3.29% to $5.6 million in 2022, then decreased by 27.45% to $4.1 million in 2023, then decreased by 27.34% to $3.0 million in 2024, then skyrocketed by 56.38% to $4.6 million in 2025.
  • Its Non-Current Assets was $4.6 million in Q3 2025, compared to $2.3 million in Q2 2025 and $2.7 million in Q1 2025.